Health Boards
Tue-09-10-2018, 19:19 PM
If you look into the BMJ journal, you see the description of it.
What struck me was this figure on the lymphocytes.
![[Image: 45157535822_f376544dd1_o.jpg]](https://farm2.staticflickr.com/1936/45157535822_f376544dd1_o.jpg)
It was accompanied by the text “BMS-986165 demonstrated dose-dependent inhibition of lymphocyte count decreases and expression of 53 IRGs in blood (Figure 1).”
But..... unfortunately that is a too high form of English for me. I cannot grasp what they mean in relation to the figure. Can someone translate this for me into real understandable English?
When I interpret the figure then I see globally that the use of BMS-numberbla, pushes the lymphocyte count downward. But........ it is a misleading conclusion as it seems that a higher dose, does less push lympho count down than the lower dose...
Even what is startling is that the placebo seems to push down the lympho count most.
This cannot be true...
so there is some sneaky combination of text and figure that puts me in trouble....
Bill !!! Heeelp !
What struck me was this figure on the lymphocytes.
It was accompanied by the text “BMS-986165 demonstrated dose-dependent inhibition of lymphocyte count decreases and expression of 53 IRGs in blood (Figure 1).”
But..... unfortunately that is a too high form of English for me. I cannot grasp what they mean in relation to the figure. Can someone translate this for me into real understandable English?
When I interpret the figure then I see globally that the use of BMS-numberbla, pushes the lymphocyte count downward. But........ it is a misleading conclusion as it seems that a higher dose, does less push lympho count down than the lower dose...
Even what is startling is that the placebo seems to push down the lympho count most.
This cannot be true...
so there is some sneaky combination of text and figure that puts me in trouble....
Bill !!! Heeelp !
